Ultragenyx
Ultragenyx 29th September 2025 Dear Community Members: We want to take a moment to update you on UX055 the gene therapy program for CDKL5 Deficiency Disorder (CDD) currently being developed by Ultragenyx. Some of you may know the company has several late-stage programs, some of which have experienced delays. These delays have impacts on programs…